INOZYME PHARMA, INC. Interest Receivable, Current
INOZYME PHARMA, INC. had Interest Receivable, Current of $467.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-10.
Financial Statements › Notes
us-gaap:InterestReceivableCurrent · last filed 2025-03-10
- 2024-12-31: Interest Receivable, Current $467.00K.
- 2023-12-31: Interest Receivable, Current $385.00K.
- 2022-12-31: Interest Receivable, Current $115.00K.
- 2022-09-30: Interest Receivable, Current $96.00K.
| Period end | Interest Receivable, Current |
|---|---|
| 2024-12-31 | $467.00K 10-K · filed 2025-03-10 |
| 2023-12-31 | $385.00K 10-K · filed 2025-03-10 |
| 2022-12-31 | $115.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $96.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $106.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $48.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $62.00K 10-K · filed 2023-03-22 |
| 2021-09-30 | $73.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $95.00K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $122.00K 10-Q · filed 2021-05-12 |
| 2020-12-31 | $155.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $252.00K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $82.00K 10-Q · filed 2020-09-03 |
| 2019-12-31 | $104.00K 10-K · filed 2021-03-25 |